These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 544775)

  • 1. [Synthetic chemotherapeutic agents V. Antibacterial activities of thiazolo[5,4-f]quinolinecarboxylic acid derivatives (author's transl)].
    Kadoya S; Nagasaki S
    Yakugaku Zasshi; 1979 May; 99(5):483-92. PubMed ID: 544775
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic chemotherapeutic agents. I. Synthesis of 2-substituted thiazolo(5,4-f)quinoline derivatives.
    Dohmori R; Kadoya S; Takamura I; Suzuki N
    Chem Pharm Bull (Tokyo); 1976 Jan; 24(1):130-5. PubMed ID: 1269056
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic chemotherapeutic agents. III Synthesis of 3-substituted thiazolo(5,4-f)quinoline derivatives.
    Kadoya S; Suzuki N; Takamura I; Dohmori R
    Chem Pharm Bull (Tokyo); 1976 Jan; 24(1):147-55. PubMed ID: 1269057
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic chemotherapeutic agents. II. Synthesis of 2-substituted thiazolo(5,4-f)quinoline derivatives.
    Kadoya S; Takamura I; Suzuki N; Dohmori R
    Chem Pharm Bull (Tokyo); 1976 Jan; 24(1):136-46. PubMed ID: 773564
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new generation of broad-spectrum antibacterial chemotherapeutic agents belonging to the group of DNA gyrase inhibitors (derived from pyridine carboxylic acid or quinolines)].
    Roy C
    Med Clin (Barc); 1985 Jan; 84(3):106-8. PubMed ID: 2983155
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of antimicrobial agents. 1. Syntheses and antibacterial activities of 7-(azole substituted)quinolones.
    Uno T; Takamatsu M; Inoue Y; Kawahata Y; Iuchi K; Tsukamoto G
    J Med Chem; 1987 Dec; 30(12):2163-9. PubMed ID: 3681887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
    Ohno I; Ida S
    Nihon Rinsho; 1987 Mar; 45(3):577-82. PubMed ID: 3298736
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterial activity, place of action and mechanism of resistance of pulmonal effecting antibiotics (author's transl)].
    Ellorhaoui M
    Z Erkr Atmungsorgane; 1979; 152(2):153-65. PubMed ID: 463117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of some novel arylthiobenzo[f]quinolines.
    Bahuguna RP; Joshi BC; Mangal HN
    Pharmazie; 1986 Sep; 41(9):672. PubMed ID: 3797464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Syntheses of nitrogen-containing heterocyclic compounds. XXXVII. On the antimicrobial activity and syntheses of 2-phenylquinoline 1-oxides and phenyl-1,8-naphthyridines (author's transl)].
    Takeuchi I; Ozawa I; Shigemura K; Hamada Y; Ito T; Ohyama A
    Yakugaku Zasshi; 1979 May; 99(5):451-7. PubMed ID: 544770
    [No Abstract]   [Full Text] [Related]  

  • 11. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Wolfson JS; Hooper DC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):581-6. PubMed ID: 3000292
    [No Abstract]   [Full Text] [Related]  

  • 12. Side chain length is more important than stereochemistry in the antibacterial activity of enantiomerically pure 4-aminoalcohol quinoline derivatives.
    Jonet A; Dassonville-Klimpt A; Sonnet P; Mullié C
    J Antibiot (Tokyo); 2013 Nov; 66(11):683-6. PubMed ID: 23820616
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.
    Wentland MP; Bailey DM; Cornett JB; Dobson RA; Powles RG; Wagner RB
    J Med Chem; 1984 Sep; 27(9):1103-8. PubMed ID: 6381730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial and genotoxic properties of quinoline derivatives.
    Zani F; Carmellino ML
    Boll Chim Farm; 1994 May; 133(5):328-38. PubMed ID: 8068239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M; Koumaré B; Soussy CJ; Duval J
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity and resistance of 4-quinolones].
    Bauernfeind A
    Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure and biological activity of some 4-amino-3-cinnolinecarboxylic acid derivatives. QSAR analysis of cinnoline derivatives with antibacterial properties.
    Brzezińska E; Stańczak A; Ochocki Z
    Acta Pol Pharm; 2003; 60(1):15-20. PubMed ID: 12848362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents.
    El Shehry MF; Ghorab MM; Abbas SY; Fayed EA; Shedid SA; Ammar YA
    Eur J Med Chem; 2018 Jan; 143():1463-1473. PubMed ID: 29113746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action, and in vitro and in vivo activities of the fluoroquinolones.
    Fernandes PB
    J Clin Pharmacol; 1988 Feb; 28(2):156-68. PubMed ID: 3283179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.